Concepedia

Iván Caballero

IC

3

Publications

82

Citations

3

H-Index

2012

Active since

Affiliations

GlaxoSmithKline (Spain)(Current)

Iván Caballero is an author at GlaxoSmithKline (Spain) specializing in drug discovery, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2012–2016

3

Publications

3

Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease

Jennifer Riley, Stephen Brand, Michael W. Voice et al. · PLoS neglected tropical diseases · 2015 · 53 citations · Full text

, , +20

Discovery and Biochemical Characterization of <i>Plasmodium</i> Thioredoxin Reductase Inhibitors from an Antimalarial Set

Andrew J. Theobald, Iván Caballero, Isabel Coma et al. · Biochemistry · 2012 · 18 citations

, , +13

Discovery of Enhancers of the Secretion of Leukemia Inhibitory Factor for the Treatment of Multiple Sclerosis

Laura Vela, Iván Caballero, Leiping Fang et al. · SLAS DISCOVERY · 2016 · 11 citations · Full text

Rows per page

1–3 of 3